LIAISON S100

LIAISON S100 is a quantitative automated chemiluminescent immunoassays (CLIA) for the in vitro determination of protein S-100B in human serum and CSF (Cerebrospinal fluid). LIAISON S100 is intended for use as an aid in the management of patients suffering from malignant melanoma. The test has to be performed on the LIAISON Analyzer family.